Company Profile

Henan Chuangxin Biological Technology Co., Ltd. is a high-tech large-scale joint-stock enterprise integrating animal drug research and development, production, sales, and after-sales service. The company's Initial registered capital is 10.1 million yuan. In December 2012, the one-time with high score passed the acceptance of eight veterinary drug GMP production lines of the Ministry of Agriculture of the State. The production dosage forms involved powder, extraction of Chinese traditional medicine, large and small volume injections, disinfectants, feed additives and so forth. All workshops have achieved complete Automated manufacturing. Known as the GMP standard model factory of veterinary drugs in Henan Province. The company has several departments including Chuangxin Poultry Medicine Department, Xinbang Huifa Swine Medicine Department, Chuangxin Aquatic Products Department, Raw Material Department, and Overseas Development Department.
Chuangxin Biology actively cooperates with colleges and universities, and has established long-term cooperative relations with South China Agricultural University, Nanjing Agricultural University, Henan Agricultural University, Peking University of Private Economics, Zhengzhou Animal Husbandry College and other universities, actively transforming university scientific research results, and combining production, teaching and research, Combination of theory and production practice. The company has 3 doctors, 17 masters, and 83% of staff have a college degree or above. A highly educated, high-quality professional team has been built.
The company has focused on the research and development of Chinese medicine antiviral for 17 years, and has always been committed to the research of animal Chinese medicine extracts. For the first time, it put forward the concept of "Combat poison with poison" to treat viral diseases of poultry and livestock, The extract of animal traditional Chinese medicine such as toad venom was applied to veterinary drug preparation, and the exact curative effect was achieved. The three new national-level drugs Jingen Injection, Xinqi, Qingjie Mixture, and Shuanghuanglian Oral Liquid are all new breakthroughs in the application of animal extracts of Chinese medicine. In response to current food safety, the state has successively introduced relevant policies, and the implementation of prescription drugs and non-prescription drugs has imposed great restrictions on antibiotics. In order to meet the current large-scale breeding needs, the company established a special drug center for large-scale breeding farms(Groups) with green and antibiotic-free breeding. Taking traditional Chinese medicine as the main body, combined with modern technology, and taking Chinese medicine anti-virus as the breakthrough point, it has created a new health road for large-scale farms of "Three Cultivation" and "four prevention".
Chuangxin people are determined to let the world's breeders get out of the cycle of antibiotic animal husbandry and improve the quality of poultry meat. Under the new situation, Chuangxin Biotech has developed a unique approach, with the purpose of "making conscience medicine, reassuring drugs", carrying forward the traditional Chinese medicine, and improving the quality of livestock and poultry meat and eggs through traditional Chinese medicine health care and prevention methods, making treatment a redundant behavior, makes Green meat, eggs, milk and fish to come to the tables of the people of the world, and Chuangxin will surely stand out in the veterinary medicine industry. Finally, Chuangxin people are willing to work together with the majority of veterinary medicine practitioners to work hard to create human food safety.
Business Type: Manufacturer/Factory & Trading Company
Number of Employees: 47
Management System Certification: ISO 9001,ISO 14001,HSE,GMP
International Commercial Terms: FOB, CIF, CFR
Terms of Payment: LC, T/T, PayPal, Western Union
Average Lead Time: Peak season lead time: one monthOff season lead time: within 15 workdays
Number of Foreign Trading Staff: 21~50 People
Overseas Agent/Branch:

Address:	yoboo Biotechnology, Australia
Telephone:

Main Customer(s):

Company Name:	Henan yoboo Biotechnology Co., Ltd
Country / Region:	Pakistan
Products You Supply:	oxytetracycline injection

Export Year: 2019-08-01
Export Percentage: 41%~50%
Main Markets: Southeast Asia/ Mideast, Africa
Export Mode: Have Own Export License
Factory Address: No. 68, Shuanghu Avenue, Longhu Town, Xinzheng City, Henan Province, Zhengzhou, Henan, China
R&D Capacity: OEM
No. of R&D Staff: 21-30 People
No. of Production Lines: 7
Annual Output Value: US$50 Million - US$100 Million